首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Nanocrystal Colloidal Dispersion® Formulations of Poorly Water-Soluble Drugs: Formulation Design, Production and Characterization
【24h】

Nanocrystal Colloidal Dispersion® Formulations of Poorly Water-Soluble Drugs: Formulation Design, Production and Characterization

机译:水溶性差的药物的纳米晶体胶体分散体配方:配方设计,生产和表征

获取原文

摘要

Key factors affecting long-term stability of nanosuspensions were defined, which made it possible to simplify and to accelerate the formulation design of poorly water-soluble drugs. Application of Elan's NanoCrystal technology enabled improvement of oral bioavaibility of BCS class II and IV compounds. Recently implemented analytical methods as TEM, DSC and ITC provided new information on diverse properties of drug nanoformulations.
机译:确定了影响纳米悬浮液长期稳定性的关键因素,这使得简化和加快水溶性差的药物的配方设计成为可能。 Elan的NanoCrystal技术的应用可以改善BCS II类和IV类化合物的口服生物利用度。最近实施的分析方法(如TEM,DSC和ITC)提供了有关药物纳米制剂多种特性的新信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号